A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study

Figure 5

The DCA curve of the nomogram in the training and validation cohort: (a) the DCA of the nomogram for 3-year NAFLD risk in the training cohort; (b) the DCA of the nomogram for 3-year NAFLD risk in the validation cohort. The red solid line is the prediction model; the gray solid line is all NAFLD patients, and the solid line horizontal line is the non-NAFLD patients. The graph depicts the expected net benefit of each patient relative to nomogram in predicting NAFLD risk. With the extension of the model curve, the net benefit increases. Using bootstrap resampling ().

(a)

(b)